Search

You searched for "palsy"

5751 results found

Scottish budget 2026–27: Optometry Scotland welcomes continued investment in community eyecare

4 February 2026 | optometry
Optometry Scotland (OS) welcomes the Scottish Budget 2026–27, which confirms continued investment in community optometry and reinforces its established role in delivering accessible eyecare across Scotland. The Budget confirms community eyecare funding of £144.5 million for 2026–27, representing a cash...

Conference Report: Retina UK 2025

1 October 2025 | | conference report, event, meeting
The Retina UK Annual Conference 2025 took place at the Holiday Inn London in London, UK, on 20 September and was hosted both in-person and online. The event included expert speakers, healthcare professionals, and patients with lived experience with retinal...

Everyday diabetes medicine could treat common cause of blindness

16 February 2026 | research, pharma
Doctors have found that metformin, an everyday medicine for diabetes, is associated with less progression of age-related macular degeneration (AMD), the commonest cause of blindness in western countries. People with diabetes over the age of 55 years taking metformin were...

From paper to digital: Real lessons for a sustainable NHS digital future

19 February 2026 | | EYE - General
Portsmouth's OpenEyes implementation reveals why healthcare digital transformation needs honest evaluation, proper clinical leadership resourcing and realistic expectations about technology efficiency promises. Like many eye departments across the NHS, we at Portsmouth were drowning in paper. Notes went missing, handwriting...

Management of a giant pigment epithelium detachment with transition from half- to full-dose aflibercept

2 March 2026 | | EYE - Imaging, EYE - Vitreo-Retinal
This case report describes the management of a giant pigment epithelial detachment (PED) in neovascular age-related macular degeneration (nAMD) using half-dose aflibercept. An 80-year-old woman presented with a huge PED (maximum height 1338µm) and multiple risk factors for retinal pigment...

The expanding role of the optometrist

5 December 2025 | | EYE - General
Eyecare in the UK has seen significant changes in recent years, with new models of care, technological advancements and an increased emphasis on primary eyecare in some UK nations. Crucially, an ageing population demographic is set to escalate further both...

Preparing to start as a consultant

5 December 2025 | | EYE - Cataract, EYE - Glaucoma
I was just coming to the end of a fantastic glaucoma fellowship at Moorfields, during which Samad Ansari had been a colleague and friend, and soon to start as a consultant in Oxford where Rebecca Turner is Clinical Director, and...

Deliberate darkness: The systematic weaponisation of blinding in global protests

18 March 2026 | | EYE - General
As eyecare professionals, we spend our entire professional lives fighting to preserve light. We train to master the delicate microscopic topography of the cornea, the retina and the optic nerve, all with the objective of saving our patients from the...

At least 70 percent of cataract patients could benefit from toric IOL

20 March 2026 | research, Events, clinical practice
More than two-thirds of cataract patients could benefit from toric intraocular lenses (IOL), according to findings presented at 100% Optical. Consultant ophthalmologist Nigel Kirkpatrick set out how astigmatism is a significant issue for cataract surgery patients during a main stage...

Sheraz Daya awarded prestigious IIRSI gold medal for contribution to ophthalmology

20 March 2026 | Leadership, Professional development
Centre for Sight, the UK’s leading and most trusted centre of excellence for advanced eye care, innovation and life-changing results, is proud to announce that its Founder and Medical Director, Sheraz Daya, has been awarded the prestigious IIRSI Gold Medal...

Semaglutide and vision loss: A new concern for NAION risk?

4 December 2025 | | EYE - Neuro-ophthalmology
This article has been verified for CPD. Click the button below to answer a few short questions and download a form to be included in your CPD folder. Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have emerged as transformative agents in...

Optegra announces programme of engaging CPD events for healthcare community

23 March 2026 | optometry, training, CPD
Optegra continues to strengthen its commitment to clinical excellence and community partnership by announcing a series of Continuing Professional Development (CPD) events throughout 2026, open to any health care professionals in optometry. Taking place across a range of dates and...